- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02038595
The Norepinephrine Transporter: A Novel Target for Imaging Brown Adipose Tissue
March 27, 2020 updated by: Yale University
This study seeks to assess a novel imaging technique to image brown adipose tissue utilizing the norepinephrine transporter.
Study Overview
Study Type
Interventional
Enrollment (Actual)
10
Phase
- Early Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Connecticut
-
New Haven, Connecticut, United States, 06510
- Yale University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 30 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- age 18-30 yrs
- BMI < 24 kg/m2
- Caucasian
Exclusion Criteria:
- Current neuro-psychiatric illness
- substance abuse
- medical or neurological illnesses likely to affect physiology or anatomy, i.e., uncontrolled hypertension, cardiovascular disorders
- current pregnancy
- current breast feeding
- suicidal ideation or behavior
- use of medications which potentially affect NET binding within 2 weeks of the PET scans.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Healthy subjects
Healthy subjects (male, female)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
detection of brown adipose tissue based on PET imaging
Time Frame: 1 year
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Robert Sherwin, MD, Yale University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2012
Primary Completion (Actual)
December 1, 2013
Study Completion (Actual)
December 1, 2013
Study Registration Dates
First Submitted
January 10, 2014
First Submitted That Met QC Criteria
January 14, 2014
First Posted (Estimate)
January 16, 2014
Study Record Updates
Last Update Posted (Actual)
March 30, 2020
Last Update Submitted That Met QC Criteria
March 27, 2020
Last Verified
July 1, 2015
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 1008007284
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Brown Adipose Tissue
-
Clinical Nutrition Research Centre, SingaporeInstitute of Bioengineering and Bioimaging (IBB)Completed
-
National Institute of Diabetes and Digestive and...RecruitingMolecular, Cellular, and Genetic Characterization of Human Adipose Tissue and Its Role in MetabolismBrown Adipose Tissue (BAT) Physiology | Phenotyping | Brown AdipocytesUnited States
-
Pennington Biomedical Research CenterCompletedBody Composition | Brown Adipose TissueUnited States
-
Maastricht UniversityCompletedDiet-induced Thermogenesis | Brown Adipose Tissue ActivationNetherlands
-
University Hospital, Basel, SwitzerlandCompletedBrown Adipose TissueSwitzerland
-
Pennington Biomedical Research CenterCompletedBrown Adipose Tissue | ThermogenesisUnited States
-
University Hospital, Basel, SwitzerlandCompletedBrown Adipose TissueSwitzerland
-
Susanna SøbergCompletedObesity | Type 2 Diabetes | Adipokines | Brown Adipose Tissue | Proteomics | Infrared Thermography | Adipose Tissue, Brown | Uncoupling Protein 1 | Brown Fat | BAT | ProteinsDenmark
-
University Hospital, LinkoepingCompleted
Clinical Trials on PET imaging
-
University of Wisconsin, MadisonTerminatedHead and Neck Cancer | Esophageal Cancer | Lung Cancer | Prostate Cancer | CNS Brain MetastasesUnited States
-
Ankara UniversityAnkara Yildirim Beyazıt University; Saglik Bilimleri Universitesi; Liv Hospital...RecruitingChemotherapy Effect | Pleural Mesothelioma | Treatment ResponseTurkey
-
Kepler University HospitalActive, not recruiting
-
Ontario Clinical Oncology Group (OCOG)Ontario Ministry of Health and Long Term CareCompletedNon-small-cell Lung CarcinomaCanada
-
Jules Bordet InstituteCompletedColorectal Cancer Metastatic | Early Response Evaluation | Fdg-PETBelgium
-
Fundacion Clinic per a la Recerca BiomédicaNot yet recruitingCardiac Disease | Device Related InfectionSpain
-
King's College LondonCHDI Foundation, Inc.Recruiting
-
Jeremy KoppelNational Institute of Mental Health (NIMH)RecruitingLate Onset Schizophrenia | Delusional Disorder (Late Onset)United States